Core Viewpoint - BeOne Medicines Ltd. has granted restricted stock units (RSUs) to 375 participants under the 2016 Option and Incentive Plan, totaling 34,361 American Depositary Shares (ADS), equivalent to 446,693 shares, representing approximately 0.03% of the company's total issued shares as of the announcement date [1]. Summary by Relevant Sections Grant Details - Grant Date: August 8, 2025 - Number of Participants: 375 - Total Number of RSUs Granted: 34,361 ADS - Total Number of Related Shares: 446,693 - Grant Price: $288.18 per ADS (approximately HKD 174.02 per ordinary share) [1]. Vesting Schedule - RSUs will vest 25% annually on the last trading day of each month for four years, contingent on the participants maintaining a service relationship with the company [1]. - For four non-senior management participants, RSUs will vest 25% annually on July 31 for four years, also contingent on continued employment [1]. Additional Information - The RSUs granted do not have performance targets and are considered competitive and in line with the company's practices [1]. - After this grant, there are still 59,660,288 shares available for future grants under the 2016 Option and Incentive Plan [1].